Smith & Nephew chief stricken with cancer, will continue to lead the company through treatment period

• In a regulatory filing, Smith & Nephew (NYSE:SNN) discloses that CEO Olivier Buhuon has been diagnosed with an undisclosed but highly treatable cancer. His treatment will begin later this month and continue into the fall. He will continue to be active in leading the company during this time but Chairman Roberto Quarta will step in if needed.
• Mr. Buhuon will present the company's Q4 and full-year results on Thursday, as usual.